Skip to main content
SpringerLink
Log in

Antineoplastics

Myelodysplasia and failure of therapy: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Tabbara N, et al. Anti-CD19 CAR T-cell therapy remission despite prior anti-CD19 antibody Tafasitamab in relapsed/refractory DLBCL. Leukemia Research Reports 16: 2021. Available from: URL: http://doi.org/10.1016/j.lrr.2021.100260

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastics. Reactions Weekly 1873, 38 (2021). https://doi.org/10.1007/s40278-021-02461-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-02461-2

Search

Navigation